Floatz logo

Cerezyme

Gaucher Disease Type III

SanofiPhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Gaucher Disease Type III cohort.

Asset / SponsorPhaseRating
Elelyso
Ari Zimran
Phase 4BB
Eliglustat
Sanofi
Phase 3BB
Venglustat
Sanofi
Phase 3B
Velaglucerase Alfa
Shire
Phase 1/2CCC
Arimoclomol
ZevraDenmark
Phase 2CCC

View all 9 →

Same molecule, other indications

Cerezyme is also rated in:

Gaucher disease type IDormant
A
Indicative ·
83 / 100
View asset →
Gaucher diseaseDormant
A
Indicative ·
81 / 100
View asset →
Gaucher Disease, Type 1Dormant
A
Indicative ·
81 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →